Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults

Infectious Disease Reports

Volumn 4, Issue 2, 2012, Pages 134-139

  Barton, James C ^a,b   Barton, J Clayborn ^a   Bertoli, Luigi F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Herpes zoster; Human leukocyte antigen; Hypogammaglobulinemia; Immune deficiency

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGE; AGED; ARTICLE; CELL COUNT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HERPES ZOSTER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; MAJOR CLINICAL STUDY; MALE; POSTHERPETIC NEURALGIA; PREVALENCE; RASH; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TRIGEMINUS NEURALGIA; UNITED STATES;

EID: 84866780096     PISSN: None     EISSN: 20367449     Source Type: Journal    
DOI: 10.4081/idr.2012.e34     Document Type: Article

References (56)

1. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008;57:1-30.
2. Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748-753.
3. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
4. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008;112:277-286.
5. Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. Ann N Y Acad Sci 2011;1246:41-49.
6. Schroeder HW Jr, Zhu ZB, March RE, et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 1998;4:72-86.
7. Barton JC, Bertoli LF, Acton RT. HLA-A and-B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama. BMC Med Genet 2003;4:3.
8. Alper CA, Marcus-Bagley D, Awdeh Z, et al. Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SC01, DR3] conserved extended haplotype. Tissue Antigens 2000;56:207-16.
9. Vorechovsky I, Cullen M, Carrington M, et al. Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 2000;164:4408-4416.
10. Asherson GL, Webster AD. Late-onset hypogammaglobulinemia. In: Diagnosis and treatment of immunodeficiency. London: Blackwell Scientific; 1980.
11. Conley ME, Park CL, Douglas SD. Childhood common variable immunodeficiency with autoimmune disease. J Pediatr 1986;108: 915-922.
12. Iglesias AJ, Matamoros FN. [Common variable immunodeficiency. Review]. Allergol Immunopathol (Madr) 2001;29:113-118.[Article in Spanish]
13. Hegazi MO, Kumar R, Alajmi M, et al. Coexistence of common variable immunodeficiency (CVID) with idiopathic thrombocytopenic purpura (ITP). Iran J Immunol 2008;5:64-67.
14. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190-197.
15. Aghamohammadi A, Louganis V, Plebani A et al. Predominantly antibody deficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo D, eds. Immunodeficiency diseases: definition, diagnosis, and management. Berlin: Springer-Verlag; 2000. pp 97-130.
16. Acton RT, Harman L, Go RC, et al. Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North Carolina. Transplant Proc 1993;25:2404-2407.
17. Murphy CC, Acton RT, Barger BO, et al. Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequencies. Clin Genet 1983;23:405-414.
18. Barton JC, Edwards CQ, Bertoli LF, et al. Iron overload in African Americans. Am J Med 1995;99:616-623.
19. Shulman G, Gilich GC, Andrew MJ. Serum immunoglobulins G, A and M in White and Black adults on the Witwatersrand. S Afr Med J 1975;49:1160-114.
20. Lewis M, Miyashiro M, Huton J, et al. Immunoglobulin and IgG subclass levels in the African American and Hispanic populations of east Harlem. Mt Sinai J Med 1998;65:139-145.
21. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
22. Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005;5:68.
23. Schmader K, George LK, Burchett BM, et al. Racial differences in the occurrence of herpes zoster. J Infect Dis 1995;171:701-704.
24. Opstelten W, van Essen GA, Schellevis F, et al. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006;16: 692-695.
25. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-1609.
26. Tyring S, Belanger R, Bezwoda W, et al. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 2001;19:13-22.
27. Whitley RJ, Soong SJ, Dolin R, et al. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med 1982;307: 971-975.
28. Locksley RM, Flournoy N, Sullivan KM, et al. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985;152:1172-81.
29. Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011;86:88-93.
30. Soderstrom T, Soderstrom R, Bengtsson U, et al. Clinical and immunological evaluation of patients low in single or multiple IgG subclasses. Monogr Allergy 1986;20: 135-142.
31. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, et al. Autoimmune disease and gender: Plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012;38:J109-J119.
32. Selmi C, Brunetta E, Raimondo MG, et al. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 2012;11: A531-A537.
33. Cauda R, Prasthofer EF, Tilden AB, et al. Tcell imbalances and NK activity in varicellazoster virus infections. Viral Immunol 1987;1:145-152.
34. Baadsgaard O, Lindskov R, Geisler C. Reduction of the number of immunocompetent cells in the acute stage of herpes zoster. Arch Dermatol Res 1987;279:374-378.
35. Burke BL, Steele RW, Beard OW, et al. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982;142:291-293.
36. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003;188: 1336-1344.
37. Stone KD, Feldman HA, Huisman C, et al. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol 2009; 131:41-49.
38. Hayward A, Giller R, Levin M. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes. Viral Immunol 1989;2:175-184.
39. Marshall JD, Wen Y, Abrams JS, et al. In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. Cell Immunol 1993;152:18-34.
40. Hayward AR, Herberger M, Lazslo M. Cellular interactions in the lysis of varicella-zoster virus infected human fibroblasts. Clin Exp Immunol 1986;63:141-146.
41. Brugnoni D, Airo P, Lebovitz M, et al. CD4+ cells from patients with common variable immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulation. Pediatr Allergy Immunol 1996;7:176-179.
42. Ravanbakhsh M, Sarafnejad A, Aghamohammadi A, et al. CD40 ligand expression on stimulated T-helper lymphocytes in patients with common variable immunodeficiency. Iran J Allergy Asthma Immunol 2007;6:129-135.
43. Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007;178: 3932-3943.
44. Tilden AB, Cauda R, Grossi CE, et al. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells. J Immunol 1986;136:4243-4248.
45. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989;320:1731-5.
46. Levy O, Orange JS, Hibberd P, et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 2003;188: 948-953.
47. Arvin AM, Koropchak CM. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. J Clin Microbiol 1980;12:367-374.
48. Moyner K, Michaelsen TE. IgG subclass distribution among antibodies to varicellazoster virus in human varicella/zoster immunoglobulin preparations and the corresponding donor plasma. J Biol Stand 1988;16:157-164.
49. Candore G, Campagna AM, Cuppari I, et al. Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases. Ann N Y Acad Sci 2007; 1110:151-158.
50. Price P, Witt C, Allcock R, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167:257-2574.
51. Descamps B, Jungers P, Naret C, et al. HLAA1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. Digestion 1977;15: 271-277.
52. Czaja AJ, Carpenter HA, Santrach PJ, et al. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995;108:157-164.
53. Steel CM, Ludlam CA, Beatson D, et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988;1: 1185-1188.
54. Kaslow RA, Duquesnoy R, VanRaden M, et al. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of Thelper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 1990;335:927-930.
55. Cameron PU, Mallal SA, French MA, et al. Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol 1990;29:282-295.
56. Schmader K, George LK, Newton R, et al. The accuracy of self-report of herpes zoster. J Clin Epidemiol 1994;47:1271-1276.